Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIA vs Regional Blockade for HTO Pain
NCT01537146Phase 4Completed
- Start
- Apr 2010
- Primary completion
- Dec 2015
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine hydrochloride liposomal suspension injection in osteoarthritis (OA) (2 arms). Primary endpoint: PN morphine consumption at 24 hours. Started Apr 2010; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01537146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01537146.